Suppr超能文献

肝移植后衰弱、死亡率和医疗保健利用:来自多中心肝移植功能评估(FrAILT)研究。

Frailty, mortality, and health care utilization after liver transplantation: From the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study.

机构信息

Department of MedicineUniversity of California-San FranciscoSan FranciscoCaliforniaUSA.

Department of Epidemiology and BiostatisticsUniversity of California-San FranciscoSan FranciscoCaliforniaUSA.

出版信息

Hepatology. 2022 Jun;75(6):1471-1479. doi: 10.1002/hep.32268. Epub 2021 Dec 29.

Abstract

BACKGROUND AND AIMS

Frailty is a well-established risk factor for poor outcomes in patients with cirrhosis awaiting liver transplantation (LT), but whether it predicts outcomes among those who have undergone LT is unknown.

APPROACH AND RESULTS

Adult LT recipients from 8 US centers (2012-2019) were included. Pre-LT frailty was assessed in the ambulatory setting using the Liver Frailty Index (LFI). "Frail" was defined by an optimal cut point of LFI ≥ 4.5. We used the 75th percentile to define "prolonged" post-LT length of stay (LOS; ≥12 days), intensive care unit (ICU) days (≥4 days), and inpatient days within 90 post-LT days (≥17 days). Of 1166 LT recipients, 21% were frail pre-LT. Cumulative incidence of death at 1 and 5 years was 6% and 16% for frail and 4% and 10% for nonfrail patients (overall log-rank p = 0.02). Pre-LT frailty was associated with an unadjusted 62% increased risk of post-LT mortality (95% CI, 1.08-2.44); after adjustment for body mass index, HCC, donor age, and donation after cardiac death status, the HR was 2.13 (95% CI, 1.39-3.26). Patients who were frail versus nonfrail experienced a higher adjusted odds of prolonged LT LOS (OR, 2.00; 95% CI, 1.47-2.73), ICU stay (OR, 1.56; 95% CI, 1.12-2.14), inpatient days within 90 post-LT days (OR, 1.72; 95% CI, 1.25-2.37), and nonhome discharge (OR, 2.50; 95% CI, 1.58-3.97).

CONCLUSIONS

Compared with nonfrail patients, frail LT recipients had a higher risk of post-LT death and greater post-LT health care utilization, although overall post-LT survival was acceptable. These data lay the foundation to investigate whether targeting pre-LT frailty will improve post-LT outcomes and reduce resource utilization.

摘要

背景与目的

衰弱是肝硬化患者等待肝移植(LT)时不良结局的一个公认危险因素,但它是否能预测接受 LT 治疗的患者的结局尚不清楚。

方法和结果

纳入了来自美国 8 个中心的成年 LT 受者(2012-2019 年)。在门诊环境中使用肝衰弱指数(LFI)评估 LT 前衰弱情况。“衰弱”定义为 LFI 的最佳截断值≥4.5。我们使用第 75 百分位数来定义 LT 后住院时间延长(≥12 天)、重症监护病房(ICU)天数(≥4 天)和 LT 后 90 天内住院天数(≥17 天)。在 1166 例 LT 受者中,21%在 LT 前衰弱。1 年和 5 年时死亡的累积发生率为:虚弱组为 6%和 16%,非虚弱组为 4%和 10%(总体对数秩 p=0.02)。LT 前衰弱与未经调整的 LT 后死亡率增加 62%相关(95%CI,1.08-2.44);在调整体重指数、HCC、供体年龄和心脏死亡后捐献状态后,HR 为 2.13(95%CI,1.39-3.26)。与非虚弱患者相比,虚弱患者经历 LT 住院时间延长(OR,2.00;95%CI,1.47-2.73)、ICU 入住(OR,1.56;95%CI,1.12-2.14)、LT 后 90 天内住院天数(OR,1.72;95%CI,1.25-2.37)和非家庭出院(OR,2.50;95%CI,1.58-3.97)的调整后优势比更高。

结论

与非虚弱患者相比,虚弱的 LT 受者 LT 后死亡风险更高,LT 后医疗保健利用率更高,尽管整体 LT 后生存率尚可。这些数据为研究针对 LT 前衰弱是否能改善 LT 后结局和减少资源利用奠定了基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50e9/9117399/e26b65faf99a/nihms-1761805-f0002.jpg

相似文献

引用本文的文献

1

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验